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1 Introduction
Affinity chromatography is a specific type of liquid chromatography in
which the separation mechanism is based on an interaction between an
immobilized and biologically related binding agent with an applied analyte [1–3]. This method is closely tied to supramolecular interactions
in that it makes use of the selective and reversible interactions that occur in many complexes that are formed in biological systems, or mimics
of such systems. Examples of biological supramolecular interactions are
those that take place between antibodies with their antigens, enzymes
with their substrates or inhibitors, and hormones with their receptors
[1–8]. Advantages of using these interactions in affinity chromatography include the high selectivity, strong binding, and good resolution that
are made possible in this method for specific target compounds [5–8].
The stationary phase in affinity chromatography, which makes up the
immobilized component of the supramolecular complex, is often called
the “affinity ligand.” The support that contains this stationary phase is
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Figure 1 A typical sample application and elution scheme used in affinity chromatography, the on–off elution mode.

packed or placed into a column and used to selectively retain the complementary target to the affinity ligand, where this target represents the
second part of the supramolecular complex [5–7].
The most common format in which immobilized ligands and columns
are used in affinity chromatography is the on/off elution mode, as shown
in Figure 1 [5, 9]. In this format and in the presence of an application
buffer, a sample mixture containing the target analyte is applied to the
column. Non-retained components pass through the column and are
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quickly eluted, while the target interacts with the immobilized affinity ligand. To obtain and release the captured agent, a separate elution buffer
is typically used in a situation where the analyte and binding agent have
strong interactions, such as occurs for systems with association equilibrium column regeneration. This situation is possible when the supramolecular interactions that are involved in retention have an association
equilibrium constant that is less than approximately 105 or 106 M−1 [1, 7,
9–11]. constants of 106 M−1 or higher [1, 7–9]. To weaken these interactions, the elution buffer may have a change from the application buffer in
its pH, polarity, or ionic strength; this approach is known as “non-specific
elution”. Alternatively, the elution buffer may contain a competing agent
to promote analyte elution by mass action, giving a method referred to
as “biospecific elution” [5, 9]. After the analyte has been released, the
column may then be regenerated by reapplying the original application
buffer or some similar solution [5, 9]. The system is then ready for the
next sample to be processed. In weak affinity chromatography (WAC),
the same mobile phase is used for both sample application and elution
under isocratic conditions, as well as for
Affinity chromatography has been popular for decades as a tool for
the selective purification of biological molecules [1–7]. In addition, this
technique has been used as a method for sample preparation during
chemical or biochemical analysis and as a tool for the isolation, measurement, or characterization of targets in biological, clinical, and environmental samples [1–6, 12–16]. This review will discuss recent developments in affinity chromatography and related supramolecular separation
methods. Topics that will be discussed will include advances with regard
to the types of supports, biological binding agents, and immobilization
methods that are employed in this method. New developments in the
applications of affinity chromatography will also be examined.
2 Supports for Affinity Chromatography
Many materials and matrices have been utilized as supports in affinity
chromatography. These supports can be divided into three main categories (see Table 1) [1–3, 17, 18]. The first category is natural supports,
such as agarose, dextran, and cellulose. The second group is inorganic
matrices, such as silica or glass. The third group is made up of synthetic
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Table 1 Types of Supports Used in Affinity Chromatography
General Type of Support

Examples of Supports

Natural
Inorganic
Synthetic

Agarose, cellulose, dextran, agarose-chitosan composites
Silica, aluminum oxide, titania
Polystyrenes, polyacrylamides, polysulfones, polyamides,
cryogels
Magnetic beads and particles (e.g., based on iron oxides)
Smart materials (e.g., thermoresponsive polymers)
Nanomaterials (e.g., multi-walled and single-walled
carbon nanotubes)

Miscellaneous

materials that can be used as chromatographic supports, such as polystyrene or polyacrylamide [1, 17, 18].
2.1 Natural Supports and Related Materials

Agarose is the most popular support material used in affinity chromatography for both the large- and small-scale purification of targets [3, 19–
23]. This was also the material used in the first modern separations that
were described for affinity chromatography in 1968 [3, 8, 19–21]. Agarose has a large pore size, which makes it suitable for many biomedical
separations or the immobilization of large biomolecules. The low cost,
low non-specific binding of this material for many biological agents, and
good stability of agarose over a broad pH range also make agarose appealing as a support for many applications of affinity chromatography
[20, 21]. However, the relatively low mechanical stability of agarose at
high operating pressures does limit its use as a support in analyticalscale separations based on high-performance liquid chromatography
[3, 5, 21]. Recently, a microporous membrane emulsification technique
has been used to develop monodisperse microspheres based on agarose
[24]. Beaded agarose in the form of microspheres with selected diameters and porosity is commercially available under the tradename Sepharose [3, 21, 25]. The hydroxyl groups of agarose can be partially or fully
derivatized, and several functional groups can be incorporated into this
support, such as amine, carboxyl, cyano, or sulfonate groups [21, 26–28].
Cellulose is another natural material that has been used as a support
in affinity chromatography, specifically for the purification of antibodies
or enzymes [3, 20, 29]. Currently, cellulose is not as popular as agarose
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as a support for affinity chromatography due to its lower surface area
and lower mechanical stability [3, 20]. However, cellulose in a membrane format can provide low backpressures and be used in preparative work at high flow rates [3, 30, 31]. Adsorptive cellulosic fibers have
been emerging as new support matrices for affinity chromatography due
to their high swelling capacity and good mechanical strength [32–34].
Besides agarose and cellulose, dextran-based matrices such as Sephadex, Superdex, and Sephacryl are also widely used in bioaffinity chromatography [30, 35]. Supports for which strong one-point interactions
with target proteins are required can be modified with dextran [36, 37].
In affinity chromatography this can be an advantage because multipoint
interactions with other proteins can lead to nonspecific adsorption.
Carbohydrate-based hybrid supports with a dense core (e.g., quartz)
have been used to prepare expanded-bed adsorbents for affinity separations [38–41]. Agarose [38–40] and cellulose [41] have often been employed for developing these hybrid supports. The use of expanded-bed
adsorbents helps to avoid column clogging by solid contaminants by allowing the creation of a fluidized or expanded bed during sample application [3, 20, 21, 23]. Expanded-bed adsorbents have been utilized
in such applications as protein purification [42] and isolation of monoclonal antibodies [43, 44].
2.2 Inorganic Supports

Inorganic materials such as porous silica particles and glass beads, both
modified with hydrophilic groups, are commonly used in high-performance affinity chromatography (HPAC) [3, 5, 20, 21]. These inorganic
supports have the advantages of being available in various pore sizes and
particle diameters and show good mechanical strength at the pressures
and flow rates that are used in high-performance liquid chromatography
(HPLC) [3, 5, 20, 45]. Non-modified inorganic supports do have some
disadvantages when compared to many carbohydrate supports, including their lower pH range stability and the possible presence of higher
non-specific binding [3, 20]. However, these materials can be modified
and used with a wide range of affinity ligands, and they are compatible
with target purification or analysis in applications that span from pharmaceutical and biomedical analysis to flow-based immunoassays [3, 20,
22, 45–47]. For instance, HPLC-grade silica has been used as a support to
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prepare lectin affinity microcolumns to examine binding by drugs with
structural variants of alpha1-acid glycoprotein (AGP) [48]. In another
report, rapid protein purification was obtained by using a surface-imprinted silica support [49].
Monolithic silica supports have also been receiving attention in affinity chromatography [50–52]. There are several advantages of monoliths over traditional particulate supports, including their availability
in a range of sizes and shapes [21, 50]. Other advantages of monolithic
supports consist of their low backpressures, high permeability, and good
separation efficiencies [21, 50]. In one report, a hybrid organic-silica affinity monolith support was made using “thiolene” click chemistry to immobilize an aptamer that was then applied to recognize a trace protein
[53]. WAC has been increasingly applied to study interactions in biological systems [54, 55]. In one recent study, silica-based monolith nanocolumns were made using a small amount of targeted protein and used
in WAC coupled with mass spectrometry for rapid fragment screening,
as may be used in the future as a tool for drug discovery [56].
Other inorganic-based supports have been considered for use in affinity columns. An example of one such material is titania, or TiO2 [57–62].
Supports that contain titania have been employed in a method known
as metal oxide affinity chromatography, or MOAC, to bind and capture
targets such as phosphopeptides [57–60]. In addition, dendritic polyglycerol-coated chitosan nanomaterials that contained Ti4+ and titania
nanoparticles have been utilized for the isolation and separation of glycopeptides and phosphopeptides [61, 62].
2.3 Synthetic Supports

Synthetic polymers such as polystyrene and polymethacrylate have also
been used as supports for both traditional and high-performance applications of affinity chromatography [3, 21, 30]. Polystyrene supports have
been used as a perfusion media and in other separation formats in affinity chromatography [21, 63, 64]. The long hydrophobic backbone of
polystyrene can lead to high levels of non-specific interactions with biological molecules like proteins, but this can be addressed by coating a hydrophilic layer on this material [21, 63, 64]. Polymethacrylates are more
hydrophilic in nature and can be used either in their original or modified forms for affinity separations [46, 50]. Other synthetic polymers
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such as polysulfones and polyamides are also used in affinity chromatography as membrane supports [65]. These organic polymers are often stable over a broad pH range, which is appealing for their use in affinity separations [3, 21, 46].
Organic polymers, agarose, and cryogels are also gaining attention
as monolithic supports in affinity chromatography [21, 50, 52, 66–77].
Polymeric monolithic supports based on glycidyl methacrylate (GMA)
and ethylene glycol dimethacrylate (EDMA) have been used with immobilized agents such as antibodies, enzymes, proteins, and peptides [52,
66–69]. For instance, polymethacrylate monoliths known as convective interaction media (CIM), have been used in a wide range of applications ranging from the purification of large biological agents such as
viruses, proteins, and DNA to antibody-based separations and immobilized metal ion affinity chromatography (IMAC) [51, 70–74]. The large
pore sizes of cryogels have made these materials useful in the separation or capture of large analytes such as eukaryotic cells and bacteria
[76, 77]. The low surface area seen in cryogels has been noted to lead
to a possible decrease in ligand density and binding capacity [75]. However, this limitation can be overcome by using small binding agents (e.g.,
metal ion chelates), surface grafting of the ligand, or embedding functionalized particles within a cryogel [78–80].
2.4 Magnetic Beads and Particles

Magnetic particles such as magnetic beads and nanoparticles have been
used in some studies as supports for affinity chromatography [81–84].
Magnetic beads are often prepared by depositing magnetic iron oxides
(i.e., Fe3O4) into porous mono-sized polymer particles, although polymers containing colloidal magnetite or other magnetic metals such as
cobalt and manganese have been used as well. Binding agents can be attached to these particles by placing reactive functional groups such as
isocyanate, vinyl, and epoxy residues on the polymers [81–84].
The use of magnetic beads or particles with immobilized binding
agents was described as early as 1977 when agarose-polyacrylate beads
containing magnetic cores were prepared and used in a sandwich immunoassay with an enzyme label [81, 83]. Several other types of magnetic beads that could be used with affinity ligands were developed after this, including materials made from starch, carbohydrate, cellulose,

Wo o l f o r k e t a l . i n A dva n c e s i n C h r o m at o g r a p h y 5 8 ( 2 0 2 1 )

9

or dextran and containing iron oxide; magnetic beads were also prepared from iron oxide and polymers such as acrylates, methacrylates,
or styrene [81, 83, 85]. The use and performance of these initial forms
of these beads in a magnetic field suffered from variability in the beads’
sizes and levels of magnetism [81, 83]. These limitations were later overcome with the preparation of magnetic beads with more uniform sizes
(e.g., spherical monodisperse particles with sizes in the range of 0.5 to
100 μm) [83].
Magnetic particles have been used as supports in several affinity separations [86–95]. These materials have been used to bind targets such as
antibodies or other proteins, antigens, and DNA or RNA [86–94]. For instance, magnetic poly(2-hydroxyethylmethacrylate) beads were used to
isolate lysozyme from aqueous solutions and egg white and cytochrome
c from an aqueous sample [84, 88]. Magnetic attapulgite, containing boronic acid as a binding agent, was used as a support for the selective enrichment of several nucleosides from urine samples [90]. Trace ginsenosides were separated from rat plasma by using magnetic nanoparticles
and a boronate as the binding agent [93]. The dye Cibacron Blue 3GA was
coupled to magnetic support made of Fe3O4 particles entrapped by polyvinyl alcohol and used for the purification of lysozyme and alcohol dehydrogenases from clarified yeast homogenates [94]. Magnetic nanoparticles containing Fe3O4 were used for the extraction of luteolin from honey
samples using boronic acid as the affinity ligand [96].
2.5 Smart Materials

A number of smart materials have been explored for use in affinity chromatography. Smart materials, or stimuli-responsive intelligent materials,
are polymers which respond to external chemical, physical, or biochemical
factors [97–99]. These polymers change their structure or function (e.g.,
an alteration in their shape, phase, or ability to take part in molecular recognition) as they respond to changes in factors such as temperature, ionic
strength, solvent concentration, UV radiation, magnetic fields, pH, or the
presence of a given binding agent or type of ion. These polymers are then
able to return to their initial state once the source of the external stimulus has been removed or reversed [97–99]. Stimuli-responsive polymers
can also be either mixed physically or conjugated with a biomolecule to
form materials for affinity-related applications [99–101].
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The smart materials that are most often used in affinity chromatography are those that respond to a temperature change (i.e., thermoresponsive polymers) [100–103]. These polymers show temperature-dependent hydrophobic/hydrophilic variations and conformational changes in
their polymer chains in response to variations in the surrounding temperature [100–104]. Examples of common thermoresponsive polymers
that have been used in bioseparations are poly-(N-isopropylacrylamide),
poly(vinyl) ether, oligo(ethylene glycol) methacrylate, and related derivatives [102, 104–107]. Among these, oligo(ethylene glycol) has been of
particular interest [100– 107]. An application mentioned in Section 2.4
was the use of boronic acid on oligo(ethylene glycol)-based magnetic
nanoparticles as thermoresponsive supports for the extraction of luteolin from honey [96]. A support for the capture and release of lysozyme
from human urine was described that made use of oligo(ethylene glycol)
and a methacrylate-based molecularly imprinted polymer [108]. Bovine
serum albumin (BSA) was purified from protein mixtures and samples
by using a thermal- and salt-sensitive molecularly imprinted polymer
(MIP) as the support [109].
2.6 Nanomaterials

Nanomaterials have yet to be widely examined for use as affinity ligands
[110]. However, there have been reports of using nanomaterials to develop stationary phases that can be used in some chiral separations [111–
113]. Carbon nanotubes have been shown to have some chiral recognition [114]. Both multi-walled and single-walled carbon nanotubes have
been embedded in monoliths and used to separate enantiomers of various organic small molecules [115, 116]. For instance, an organic monolith
containing multi-walled carbon nanotubes was used to separate the enantiomers of bupivacaine, dansyl‐methionine, dansyl‐phenylalanine, and
2,4‐dichlorophenoxypropionic acid [115]. A monolith containing singlewalled carbon nanotubes was used in chiral separations for sulconazole,
nomifenzine, etozoline, chlorpheniramine, and celiprolol [116].
2.7 Support Formats

Several forms of support have been utilized in affinity chromatography
[3, 20, 21]. The majority of reports on this method have used packed
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columns for either low-to-medium performance affinity chromatography (e.g., using agarose or cellulose) or HPAC (e.g., based on silica or
glass beads) have used packed columns [3, 21, 30]. Small volume columns, including short length or small internal diameter columns, have
also been of interest in recent years [3, 117–119]. Over the past decade,
monoliths and perfusion-based media have both gained popularity in
analytical and preparative applications of affinity chromatography [3,
21]. Expanded or fluidized beds have also become popular for preparative uses of affinity chromatography [3, 20, 21].
Several types of supports (e.g., capillaries, packed beds, and monoliths) have been considered for use in microchips and miniaturized devices for affinity-based separations and methods [21, 120–126]. The advantages of using these supports for affinity chromatography are that
they require a smaller amount of binding agent than more traditionalsized columns and consume less mobile phase. They also usually require
smaller sample injection volumes and can often provide a short analysis time [120, 126].
Packed capillaries in these methods usually have an internal diameter
of 75–500 μm and a length of 5–15 cm [120, 127–129]. They are typically
used at low flow rates (i.e., nL/min to μL/min) and are often employed
with nano-HPLC or microbore HPLC systems [120, 127–129]. Capillary
columns with IMAC-based stationary phases have been used in the purification and biointeraction studies of several proteins [127, 128]. For
example, Ti4+ complexed on monodisperse-porous silica microspheres
was used in a capillary column for the purification of phosphoproteins
from milk and human serum [128]. Monolithic capillary columns containing Cu2+ were employed for the isolation of immunoglobulin G (IgG),
transferrin, and albumin from human plasma [127]. A microfluidic affinity capillary microcolumn was made that contained a MIP formed by
the interaction of a cis-diol containing-template, β-nicotinamide adenine nucleotide, and the functional monomer, 4-vinylphenylborononic
acid; this boronic acid monolith was then employed for the purification
of β-nicotinamide adenine nucleotide [129]. Packed capillaries as affinity columns have also been employed for studying the interaction of
drugs with serum proteins and identification of ligands specific to the
adenosine A2A receptor [120, 130].
Short affinity microcolumns having a length of 5–50 mm and a typical internal diameter of 2.1 mm have also been employed in several
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studies [48, 131–142]. These microcolumns usually have low backpressures, which allows their use at high flow rates [48, 131–137, 139–
142]. These microcolumns have been used in applications such as studies of drug interactions with AGP or human serum albumin (HSA) by
zonal elution, frontal analysis, and ultrafast affinity extraction [48,
131–137, 139– 142]. These microcolumns have been employed in biointeraction studies involving AGP and the lectins concanavalin A (Con
A) and Aleuria aurantia lectin (AAL) [48] and in work examining binding by drugs such as tapsin derivatives with epidermal growth factor
receptors [138].
Two other microscale formats that have been used in affinity chromatography are microchips and microfluidic flow cells [121, 126, 143,
144]. For example, a polymer chip that contained TiO2-ZrO2 was employed for the enrichment of phosphopeptides from a tryptic digest of
β-casein based on MOAC [143]. Con A was immobilized on regenerated bacterial cellulose in a microchip and was used for the separation
of lysozyme from transferrin [144]. Microfluidic frontal affinity chromatography based on Ste2-G-protein-coupled receptor on a gold substrate held in a flow cell was used to study the interaction of this receptor with α-factor, a natural pheromone peptide [121]. Biotin–avidin
interactions in a flow cell have been exploited for the detection of HIV1, based on dual labeling of amplification products specific to the HIV-1
gene by using biotin and fluorescent tags and passing these products
through streptavidin agarose beads [145].
3 Immobilization Methods
The choice of immobilization technique for preparing affinity columns
is an important factor to consider. Figure 2 shows several immobilization techniques that can be used when preparing affinity columns. It is
essential that the correct immobilization scheme is selected for a particular application because several effects that can result from immobilization schemes can alter the actual or apparent activity of an immobilized binding agent [1, 146–148]. These factors include steric hindrance,
multisite attachment, and improper orientation of the affinity ligand [3,
147, 148].
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Figure 2 General types of immobilization schemes used in affinity chromatography.

3.1 Non-Covalent Immobilization
Non-covalent immobilization techniques based upon the physical adsorption of affinity ligands to chromatographic the supports were employed initially. In this approach, depending on the properties of supports and affinity ligands, physical adsorption of the binding agent to the
support may occur through electrostatic interactions, hydrophobic interactions, or hydrogen bonding [44, 148]. Both natural supports (e.g.,
agarose and cellulose) and inorganic supports (e.g., alumina and silica)
have been used for non-covalent immobilization [149, 150]. This approach is simple [3, 149] but suffers from the possibility of limited stability of the resulting affinity support and the loss of binding agent activity through random orientation [149].
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Non-covalent immobilization can also be obtained through biospecific adsorption. In this approach, a secondary ligand is attached to a
support that can then bind and immobilize the primary affinity ligand
[3, 151]. The most common examples of such an approach are to use
biotin as a tag on a binding agent that is then allowed to bind to a support that contains avidin or streptavidin [149, 152, 153]. Another popular example of biospecific adsorption is the use of protein A or protein
G (i.e., immunoglobulin- binding proteins) on supports to bind and immobilize antibodies [154–156].
Entrapment or encapsulation is another form of non-covalent immobilization. This approach makes use of the physical encapsulation
or trapping of an affinity ligand within the pores of a support or within
a cross-linked support or polymer network [157]. Enzymes, proteins,
and other affinity ligands have been entrapped for a number of years
within silicate-based sol-gels [157–159]. Another pathway for entrapment is the use of a cross-linking agent to immobilize an affinity ligand
onto a support [3, 131, 160–162]. Hydrazide-activated silica supports
combined with oxidized glycogen as a capping agent have been used
to entrap HSA, AGP, IgG, and other agents [131, 160, 162–164]. This
latter method was also used with an online immunoextraction/entrapment system to extract and place a serum protein (i.e., HSA and modified forms of this protein) within small affinity columns for use in drugbinding studies [163].
Another immobilization method that has seen much interest in recent years is one that is based on boronic acids [165–170]. This approach makes use of the interaction of a boronic acid with the vicinal
diol groups in many carbohydrate groups to generate boronate esters.
To accomplish this, the surface of the support should first be modified
with boronic acid derivatives such as aminophenylboronic acid [166–
170]. Although this technique avoids the need to carry out prior modification of the carbohydrate groups, the reaction of diol groups with boronic acids is usually reversible at a physiological pH [165, 171, 172].
In addition, there may be competition between different classes of glycoproteins or carbohydrate-containing agents for immobilization onto
this type of support [165]. However, such competition can be avoided
by the formation of aldehydes via glycoengineering and/or enzymatic
oxidation methods and incorporating unnatural fucose derivatives into
the carbohydrate moieties [171, 173–176].
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3.2 Covalent Immobilization
Covalent immobilization is the most widely used method for coupling an
affinity ligand to a support material [1, 146, 148]. This technique usually requires that the ligand or support, or both, be activated prior to immobilization. Examples of covalent immobilization methods are the cyanogen bromide (CNBr) method, the Schiff base (reductive amination)
method, and approaches that use activating agents such as carbodiimide
[146, 148, 177–179]. Many other techniques for this purpose have also
been described, as reviewed previously [146, 148].
The CNBr method is a two-step process which involves an initial modification of hydroxyl groups on the support to obtain active cyanate esters or imidocarbonate groups; these groups can then undergo a reaction with primary amine groups on affinity ligands to form a covalent
linkage [146, 148, 180]. Examples of recent applications for this method
include its use in the activation of a Sepharose 4B support for the immobilization of sulfanilamide and the activation of a cryogel monolith for
the immobilization of HSA [181, 182]. Although this method remains a
common technique for the immobilization of affinity ligands to materials like agarose, it does suffer from health and safety issues related to
the toxicity of its reagents and side-products [18].
The Schiff base method involves the use of a support that has been activated or converted into a form that contains aldehyde groups or amine
groups. These groups are then combined with a ligand that has primary
amine groups or aldehyde groups, respectively, to form a Schiff base. Because a Schiff base is a reversible bond, this reaction is usually conducted
in the presence of a mild reducing agent such as sodium cyanoborohydride to create a more stable secondary amine linkage [148]. This immobilization method has been used in a number of recent reports for the
immobilization of HSA to silica for drug-protein binding studies [132,
183]. This method has also been employed in the immobilization of antihuman serum transferrin antibodies, anti-HSA antibodies, and the lectin Con A onto maltose-bonded silica for use in HPAC [184].
One example of a carbodiimide activation method is to activate carboxylic groups on a support by using a carbodiimide such as 1-ethyl3-(3-dimethylaminopropyl) carbodiimide (EDC) in the presence of
N-hydroxysuccinimide (NHS) [185]. The result of this process is a stable-but-reactive NHS ester. The activated NHS ester groups can then be
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reacted directly with primary amine groups on an affinity ligand such
as a protein or peptide through amide bond formation [185]. The carbodiimide activation method has been used recently for the immobilization of gelatin onto a poly(hydroxyethyl methacrylate) cryogel and
peptides onto agarose supports [186, 187]. The carbodiimide activation technique has also been used for the immobilization of Con A onto
silica [188]. Other studies have used NHS-activated supports that have
been produced without the use of carbodiimides. For example, NHS-activated silica has been created by reacting succinic anhydride with aminopropyl silica, and subsequently reacting this product with NHS, as
well as by combining disuccinimidyl suberate with aminopropyl silica
[146, 148, 177–179].
Multisite attachment and improper orientation remain as challenges
that are often associated with covalent immobilization through primary
amine groups and other relatively common functional groups [148].
These challenges can be avoided by employing covalent immobilization
methods that use more site-selective sites on an affinity ligand, such as
free sulfhydryl groups [146, 148, 189, 190]. This latter method has been
used for immobilization of protein A, protein G, and HSA onto supports
such as agarose beads and silica for affinity-based separations [190–
192]. This approach has also been used to immobilize peptides such as
glutathione onto agarose for the purification of fusion proteins and peptide-specific antibodies [193, 194]. Although covalent attachment of affinity ligands to supports via sulfhydryl groups is attractive as a siteselective immobilization option, the aggressive conditions required to
generate the sulfhydryl groups on certain ligands may also result in undesired reactions that can alter the binding characteristics of the ligand
[165, 195–197].
For sugars and glycoproteins, including antibodies, improper orientation and multisite attachment effects can be significantly minimized
by covalent coupling through carbohydrate groups [146, 148, 198–204].
In this approach, initial oxidation of the carbohydrate group is first carried out by oxidizing agents like periodate or by an enzymatic reaction to
form aldehyde groups [148, 199, 203, 205]. Hydrazide or amine groups
that have been placed on the support can then be reacted with these aldehydes to covalently attach the ligand [200–203, 205]. The main challenge with this approach is that certain important amino acids such as
histidine, methionine, and tryptophan may be oxidized along with the
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carbohydrates by periodate, thus altering the site selectivity and binding properties of the binding agent [195–197]. Therefore, care must be
taken to use mild oxidation conditions [148].
4 Binding Agents Used in Affinity Chromatography
4.1 Biological Agents as Affinity Ligands
The first use of a biological binding agent as a stationary phase in affinity chromatography can be traced back to 1910 when Starkenstein
used starch as a support to isolate α-amylase [206]. This type of affinity chromatography is now commonly called bioaffinity chromatography [1, 3]. This general method gained popularity for the isolation of
enzymes and other biological agents following the work in 1968 by Cuatrecasas et al., who used columns containing nuclease inhibitors to isolate α-chymotrypsin, carboxypeptidase A and staphylococcal nuclease
[3, 19, 151]. Over the past 50 years, bioaffinity chromatography has remained one of the most common types of affinity chromatography [3,
18, 22, 30, 151]. Examples of biological agents that can be used as affinity ligands are shown in Table 2. This section will examine the major
types of affinity ligands that consist of biological agents and new developments that have taken place with such stationary phases.
4.1.1 Immunoaffinity Chromatography

Immunoaffinity chromatography (IAC) is the most common form of bioaffinity chromatography [207–210]. This method is based on the highly
specific and strong interactions that often take place between antibodies
and their target antigens. These interactions are used in IAC to capture,
isolate, and purify various biochemicals and chemical agents [208–211].
The versatility of antibodies with regard to the many types of targets
against which they can be prepared has made IAC a powerful purification method for use in many applications. These applications have included sample preparation, sample cleanup, and clinical or diagnostic
assays for drugs, hormones, toxins, and biomarkers [207–214].
Applications of IAC may involve the use of various elution and detection methods. For example, this approach has been used with pH step
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Table 2 Types of Biological Binding Agents Used in Affinity Chromatography
Type of Binding
Agent

Targets

Examples of Applications

Antibodies and
Complementary antigens or
antigens
antibodies
immunodepletion;
		

Immunoaffinity chromatography;
immunoextraction; 				

Lectins (e.g., Con A,
Glycoproteins, glycolipids,
WGA, AAL)
and polysaccharides
		
Enzymes

Lectin affinity chromatography;
glycan analysis; isolation of
carbohydrate-containing targets

Serum proteins
Various drugs and low mass
(e.g., HSA, BSA, AGP) hormones

Biointeraction studies;
chiral separations

ImmunoglobulinImmunoglobulins, antibodies,
binding proteins
and antibody fragments
(e.g., protein A, 		
protein G, protein L)

Enzyme substrates and
inhibitors
		
Biotin
Avidin or streptavidin
		
		
Carbohydrates

Lipids

Targets that bind polysaccharides or cyclic
oligosaccharides

Targets that interact with
lipids or binding agents
contained within lipid
structures
		
		
Nucleic acids and
aptamers

Targets that bind to general
or specific structures or
sequences within a nucleic
acid or aptamer
		
		

chromatographic immunoassays

Antibody purification and
analysis; biospecific adsorption
of antibodies

Purification of enzyme
inhibitors; chiral separations;
immobilized enzyme reactors

Capture or labeling of agents that
contain avidin or streptavidin;
biospecific adsorption
Chiral separations;
purification of agents that
bind carbohydrates

Immobilized artificial membrane
chromatography; immobilized
liposome chromatography;
biointeraction studies; screening
of compounds that bind to
membrane receptors

DNA affinity chromatography;
aptamer affinity chromatography;
purification and isolation of DNA
binding proteins; purification,
enrichment or analysis so small
targets that bind to aptamers

elution for the isolation of plasma and serum proteins in biological matrices, as followed by detection based on absorbance measurement or
tandem mass spectrometry [207–209]. IAC has also been used to isolate
other agents, such as glycoproteins and carbohydrates [207, 208, 212,
214]. When used for sample pretreatment, IAC has aided in the isolation
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of compounds from water or food samples for further analysis by other
liquid chromatography (LC) methods, as employed for the determination of antibiotics and toxins in such matrices [213, 215]. In addition,
IAC has also been used as the basis for chromatographic immunoassays
and has been developed using both competitive and non-competitive
binding formats [213, 216–219]. More details on recent developments
in these analytical applications are provided in Section 5.
4.1.2 Immunoglobulin-Binding Proteins

Immunoglobulin-binding proteins are another important set of biological binding agents that are used in bioaffinity chromatography [207,
220–229]. Two common examples of these agents are proteins A and G
[221–224, 228, 229]. Protein A is a surface protein found in the cell wall
of the bacterium Staphylococcus aureus [220]. Protein G is an immunoglobulin-binding protein from Streptococci bacteria. Both these binding
agents have a high affinity for the constant, or Fc, region of many types of
polyclonal or monoclonal antibodies, which makes these useful in the detection and purification of various subclasses of immunoglobulins [207,
220–223]. Although protein A and G both bind to antibodies from various species, they differ in their affinity and dependence between species and immunoglobulin types [207, 220, 224]. For example, proteins
A and G both have strong binding to most forms of human IgG-class antibodies [207, 230]. However, proteins A and G differ in their binding to
human IgM- and IgA-class antibodies [207].
Other types of immunoglobulin-binding proteins have been reported
as well. An example is protein L, which is isolated from the bacterial
strain Peptostreptococcus magnus [226, 227]. Unlike protein A and protein G, protein L binds through the light chains instead of the Fc region
of immunoglobulins. This feature gives protein L an ability to bind to a
wider range of immunoglobulin classes than proteins A and G (e.g., human IgA, IgD, IgE, IgG, and IgM) [226, 227]. Recombinant forms and
mixtures of these immunoglobulin proteins have also been employed
in affinity methods capture, purify, and measure immunoglobulins in
samples [207, 220–224, 228, 229, 231]. For example, the adsorption kinetics of recombinant human IgG antibodies with protein A was studied by affinity chromatography [222]. The affinity of protein A for IgG
from various species was also examined [223]. Protein G affinity chromatography was used to determine the amount of soluble IgG in bovine
colostrum products [224].
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4.1.3 Lectins
The use of lectins as binding agents in chromatography results in a
method known as lectin affinity chromatography (LAC) [3, 48, 220, 232,
233]. Lectins are carbohydrate- binding proteins that are highly specific
for targets that contain complementary sugar groups [220, 232, 233].
LAC has frequently been used for the isolation and separation of glycoproteins and their glycoforms, as well as glycolipids and polysaccharides, thus making this technique a valuable approach to glycan analysis [48, 232, 233]. For example, this method has been employed for the
separation and analysis of glycoforms for AGP based on lectin microcolumns [48].
Many types of lectins have been used in LAC. Two common examples
are Con A and wheat germ agglutinin (WGA), which can be utilized to
bind agents containing high-mannose type glycans or N-acetyl-d-glucosamine and sialic acids, respectively [220]. Additional lectins that have
been employed in LAC are jacalin, AAL, various types of Phaseolus vulgaris agglutinin (PHA), Datura stramonium agglutinin (DSA), Lens culinaris agglutinin (LCA), Maackia amurensis lectin (MAM), Ricinus communis agglutinin (RCA), and Sambucus sieboldiana agglutinin (SSA) [3, 48,
220]. The coupling of lectin columns for the characterization of glycans
on the same glycoconjugate is referred to as serial lectin affinity chromatography (SLAC) [234]. For example, N-glycosylated and O-glycosylated proteins have been examined by using a set of lectin columns for
the determination of glycan structures [233].
4.1.4 Enzymes

Enzymes are another group of biological agents that are often employed as ligands or targets in affinity chromatography [3, 11, 220].
Enzymes can be coupled to various chromatographic supports, including silica or monoliths, and through the use of various immobilization
methods [3, 11, 220]. Enzymes can undergo selective and stable interactions with their substrates and inhibitors, which can make enzymes valuable for the purification of enzyme inhibitors as well as for
scavenging impurities [3, 11, 220, 235–237]. For example, catalase has
been used for scavenging perborate and hydrogen peroxide, horseradish peroxidase has been employed for the removal of chlorophenols
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from wastewater, and rhodanese has been utilized for the removal of
cyanides in effluents and air [220, 236, 237]. Enzyme-inhibitor interactions have further been exploited for the purification of enzyme inhibitors, such as the use of trypsin to isolate trypsin inhibitor, and DDpeptidase to bind penicillin [220]. Trypsin has recently been entrapped
in a sol-gel monolithic column as a means to screen for N-α-benzoyl-dlarginine-4-nitroanilide hydrochloride [235]. Enzyme inhibitors have
also been extensively used for the purification of enzymes, as will be
discussed later in Section 5 [3, 11, 220].
Other applications of enzymes have involved their use in solid-phase
extraction (SPE) and immobilized enzyme reactors (IMERs) for the
screening of bioactive compounds from natural products [22, 238–242].
In such work based on IMERs, a substrate that is specific for the immobilized enzyme is introduced along with an extract of the natural product
to be examined [22, 239–242]. The immobilized enzyme is then used to
catalyze the formation of a product from the substrate and to see how
this process is affected by bioactive compounds in the natural product
extract (e.g., through competitive or non-competitive binding with the
enzyme to prevent the formation of the product) [22, 239–242]. Enzymes such as acetylcholinesterase, gelatinase, xanthine oxidase, and
adenosine deaminase have been employed in this type of scheme with
supports such as silica or sol-gel capillary monoliths and in combination
with two-dimensional LC or LC coupled with mass spectrometry [22,
237–239]. Enzymes have also been immobilized on silica and used in a
microextraction column to fish for xanthine oxidase inhibitors in natural products by using LC coupled with a diode array detector and tandem mass spectrometry [22, 238].
Some enzymes have been employed as chiral selectors [243–247].
Examples of enzyme-based chiral stationary phases (CSPs) are those
based on penicillin G acylase [243–245], glucoamylase [246], and cellulase [247]. For instance, penicillin G acylase has been covalently
immobilized with a silica monolith for the chiral separation of 2-aryloxyalkonic acid methyl esters and isosteric analogs [245]. Cellulase was recently employed as a CSP by covalently immobilizing it
onto aminopropyl silica and using this stationary phase for the chiral separation of various β-blockers [247]. Other examples are described in Section 5.3.
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4.1.5 Serum Proteins
Serum proteins are one set of biological binding ligands that have been
used for sample preparation and binding studies in affinity chromatography [11, 248, 249]. HSA, BSA, AGP, and lipoproteins are examples of
these binding agents. HSA and AGP act as the main carrier proteins for
numerous drugs, low-mass hormones, and fatty acids in the human circulatory system [11, 250, 251]. HSA is primarily involved in delivering
acidic and neutral drugs, while AGP is the main carrier for basic drugs
and steroids [250, 251].
Applications of these serum proteins in affinity separations have been
the subjects of several recent reviews and papers [252–263]. One example is their use as stationary phases in chiral separations [11, 252, 253],
as is described in more detail in Section 5.3. Another use of these serum
proteins has been in biointeraction studies (see Section 5.4) [254–262].
For example, several studies in recent years have used affinity columns
to investigate the overall affinity and site-specific binding of various solutes toward these carrier proteins [135, 141, 254–262]. The use of affinity chromatography to develop structure-affinity relationships for solutes with serum proteins has also been described [11, 135, 253, 256,
257, 261]. In these studies, a change in structure for either a group of
solutes or in the immobilized binding agent is made to see how this affects the solute-binding agent interaction. Specific examples include reports that have looked at how changes in the glycation of HSA or glycosylation of AGP affect the ability of these serum proteins to bind to
various drugs and drug classes [11, 135, 141, 262].
4.1.6 Biotin, Avidin, and Streptavidin

The interactions of biotin with the proteins streptavidin and avidin have
often been employed in affinity chromatography [220, 264–266]. Biotin,
which is also known as vitamin H and vitamin B7, is a cofactor found in
all living cells [220, 264–266]. Avidin is a glycoprotein that is found in
egg white, while streptavidin is a protein produced by Streptomyces avidinii bacteria [220, 264–267]. Biotin affinity columns are usually prepared by immobilizing 2-iminobiotin or native biotin to an LC support
by employing the valeric acid side chain of these compounds [220]. Avidin or streptavidin can also be immobilized by using an approach such
as the cyanogen bromide method [220].
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It has been known for many years that biotin can undergo strong
non-covalent interactions (i.e., with dissociation equilibrium constants
as low as the picomolar-to-femtomolar range) with avidin and streptavidin [265–267]. Although there are similar biotin interacting sites in
both these proteins, streptavidin possesses stronger binding to biotin
than avidin as it can form a greater number of hydrogen bonds with the
valeryl carboxylate group of biotin [220, 264].
Biotin–avidin interactions have been employed for carrying out the
purification of biotinylated proteins using native elution conditions as
well as for the determination of biotin in food and beverages [268, 269].
Biotin–avidin interactions have also been recently used to study the interactions of avidin on quantum dots with biotinylated IgG [270]. Interactions based on biotin with streptavidin have been used for the identification and characterization of ligands specific to nanodisc-embedded
G-protein-coupled receptors, the detection of human immunodeficiency
virus-1 (HIV-1) in sub-attomole levels, and the extraction of streptavidin in the presence of green fluorescent protein and a cell lysate of E. coli
[130, 145, 152]. A biotinylated ligand complex prepared by coupling an
azo-based linker through click chemistry was immobilized on a streptavidin support for the affinity independent elution of ligands [271].
Monolithic columns have been combined with biotin–streptavidin/
avidin systems for various applications [259, 272]. For instance, monomeric avidin that was attached to monoliths based on co-polymers
of glycidyl methacrylate with ethylene dimethacrylate and acrylamide
have been employed for the enrichment of biotinylated peptides and
proteins [272]. Streptavidin–biotin interactions were also exploited by
applying biotinylated HSA to streptavidin immobilized on silica- and
organic-based monoliths that were used in nano-weak affinity chromatography [259].
The fact that avidin and streptavidin have essentially irreversible
binding to biotin means avidin/streptavidin–biotin complexes can only
dissociate under harsh conditions, which can lead to the inactivation
of some biotinylated biomolecules [267, 273, 274]. This has made genetically or chemically modified forms of avidin or streptavidin of interest for use in affinity applications [275]. Tamavidin 2-REV, a mutein
engineered from tamavidin, was immobilized on agarose for the purification of biotinylated BSA and exhibited reversible binding for this
target (dissociation equilibrium constant, 10−7 M) [275]. Core streptavidin, a mutant of streptavidin, can undergo reversible interactions

Wo o l f o r k e t a l . i n A dva n c e s i n C h r o m at o g r a p h y 5 8 ( 2 0 2 1 )

24

with a strong affinity with biotin without being affected by harsh experimental conditions [276–279]; this form of streptavidin was fused
with the transmembrane glycoprotein CD47 and isolated by using biotinylated agarose [279].
4.1.7 Carbohydrates

Carbohydrates have been used as immobilized ligands in chromatographic methods to carry out chiral separations and other forms of selective separations (see Section 5 for examples of applications) [3, 11,
220, 280–284]. Polysaccharide-based stationary phases have been extensively used for the separation of chiral drugs and solutes as a result
of their excellent enantioselectivity and an ability to be used in a variety of separation modes [3, 11, 112, 282, 283, 285, 286]. Most CSPs that
employ polysaccharides are based on 3,5-dimethyl phenyl carbamate
or 3,5-dichloro phenyl carbamate derivatives of cellulose and amylose,
which can be prepared by coating or immobilizing these chiral agents
onto supports such as porous silica particles, silica monoliths, or superficially porous silica [11, 280, 283, 285–287].
Other polysaccharides such as derivatives of chitin and chitosan have
also been recently employed for chiral separations. Some attractive features of these polysaccharides are their insolubility in many organic
solvents (e.g., as may be used as a mobile phase) and their comparable
enantioselectivity to cellulose or amylose derivatives for some applications [281, 282]. In the case of chitin, N-acetyl-d-amine glucose units
are bonded together by β-(1→4) glycoside bonds, with deacetylation of
chitin resulting in the formation of chitosan [281, 282, 284]. Most chitosan- and chitin-based chiral selectors have made use of arylcarbamate or 3,5-dimethyl carbamate derivatives of chitosan and chitin [284,
288–295].
Cyclic oligosaccharides composed of α-1,4-linked d-glucopyranose
units, such as β-cyclodextrin, have also been frequently employed as
CSPs [11, 112, 282, 283, 296, 297]. The glucopyranose units in these cyclodextrins are arranged in a circular polymer which has a hydrophobic cavity and an exterior that is hydrophilic [112, 282, 283, 296, 297].
Some chiral solutes can form inclusion complexes with the hydrophobic cavity and undergo differential interactions to the hydroxyl groups
that are at the mouth of the cyclodextrin cavity [112, 282, 296, 297].
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Host–guest interactions between chiral solutes and cyclodextrins mainly
occur through hydrogen bonds, hydrophobic forces, π–π bonding, and/
or ionic interactions [112, 282, 296, 297]. These CSPs can be prepared
by coating or covalently immobilizing a cyclodextrin to the desired chromatographic support [11, 112]. Recently, immobilization strategies for
β-cyclodextrin using click chemistry [298–302], monolithic supports
[303], hybrid chromatographic supports [304, 305], and light-assisted
preparation of the CSP [306] have also been reported.
CSPs that are based on derivatized β-cyclodextrins may suffer from
a loss of enantioselectivity due to exhaustion of hydroxyl groups that
were originally present on the rim of the cyclodextrin or due to the steric hindrance caused by a large number of substituents at or near the rim
of the cyclodextrin [307, 308]. Several new forms of cyclodextrin supports, or studies of current cyclodextrin materials, have been recently
reported to overcome these disadvantages. For example, a bridged bis(βcyclodextrin) has been utilized as a new ligand for chiral separations and
has been noted to possess strong hydrogen bonds, synergistic inclusion
effects, and good molecular assembly, which can lead to improved chiral separations [307, 308]. This type of stationary phase consists of two
β-cyclodextrin units that are connected together by a linker such as ethylene-diamine dicarboxyethyl diamido or stilbene diamido, which has
been proposed to provide additional binding regions by creating pseudocavities [307, 308]. A chiral mixed-mode stationary phase has also been
prepared by grafting ionic liquids with β-cyclodextrin and C18 on silica;
these materials have been found to exhibit retention based on reversedphase, hydrophilic, and ion-exchange mechanisms [309].
The methods of peak profiling and peak fitting, respectively, have
been used to study the kinetics and thermodynamics of interactions by
immobilized β-cyclodextrin with various solutes [310–313]. For example, peak profiling based on both single- and multi-flow rate methods
was used to measure the apparent dissociation rate constants for various drugs with immobilized β-cyclodextrin [310, 311]. Peak fitting was
used under non-linear conditions to determine the binding and rate constants for acetaminophen, trimethoprim, ketoprofen, indapamide, and
uracil with immobilized β-cyclodextrin [310].
Macrocyclic oligosaccharides such as aliphatic and aromatic cyclofructans (CFs) have also been utilized in chiral separations [281, 314].
These compounds are classified based on the number of fructose units
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they contain in their structure, with examples being cyclofructan 6, cyclofructan 7, and cyclofructan 8 [281, 314]. These cyclofructans are either partially derivatized into an aromatic or aliphatic form and coupled
to silica or they are first combined with a silica support and then derivatized into one of these forms [281, 314–318]. Click chemistry has also
been used to prepare cyclofructan CSPs [319].
Another type of carbohydrate-related agent that has been used in
affinity separations is heparin. Heparin is a glycosaminoglycan that is
structurally related to heparan sulfate and is an important receptor for
virus attachment in mammalian cells [320]. This property means heparin can be used to bind to viral particles [320]. Based on this ability, heparin has been employed in affinity chromatography for the purification
of porcine reproductive and respiratory syndrome viral particles, and
human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae, as well as the separation of HIV-1 gag viral-like particles and extracellular vesicles [320–322].
4.1.8 Lipids

Lipids are another class of biological ligands that have been employed
in affinity chromatography and related separation methods. Phosphatidylcholine is a phospholipid that is extensively employed in applications that involve lipid supports, such as immobilized artificial membrane chromatography and immobilized liposome chromatography [3,
11]. Phosphatidylcholines are glycerophospholipids that contain a glycerol backbone, two fatty acids coupled together by ester linkages, and
a choline head group [323, 324]. Other lipids such as sphingomyelin
and cholesterol have also been employed in immobilized artificial membranes and other supports that have been used in separations [3, 11,
325]. Sphingomyelins are based on ceramide and consist of a long-chain
sphingoid base with an amide-linked acyl chain and a phosphorylcholine head group [323, 324]. Cholesterols are sterols that contain a fourring hydrocarbon structure [323, 324].
Immobilized artificial membrane chromatography, or IAM, is one format in which lipids have been employed as affinity ligands to study membrane protein–substrate interactions and membrane–drug interactions
[311, 326]. The stationary phase in IAM is prepared by covalently immobilizing a monolayer of phospholipid analogs with functional head
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groups, which are attached to silica or a polymeric monolithic support.
This type of support creates a hydrophobic environment for the adsorption and immobilization of transmembrane proteins such as receptors,
transporters, ion channels, and enzymes [326–336]. Solubilized cellular
membrane fragments can be immobilized on IAM supports through entrapment or adsorption after dialysis [326–336]. For example, voltagedependent anion channel isoform 1 (VDAC-1) has been immobilized on
lecithin-functionalized silica gel for the screening of anti-cancer compounds found in traditional Chinese medicine [330]. This receptor support was also used to study the interactions of VDAC-1 with ligands such
as NADH, ATP, and NADPH [330]. IAM has further been used to study
the partitioning of drugs into lipid monolayers to predict drug absorption and cell permeability [337–339].
Immobilized liposome chromatography, or ILC, is a type of affinity
chromatography in which lipid bilayers or proteoliposomes are immobilized on a support through non-covalent steric, electrostatic, hydrophobic, or covalent interactions [340–347]. The liposome membrane is
composed of self-aggregates of a structured phospholipid with charged
choline or phosphate groups, a carbonyl group, and a hydrophobic environment; the result is considered structurally similar to a cell membrane
[121, 348–350]. Proteoliposomes can act as biomimetic membranes to
reconstitute membrane proteins [121, 348–350]. For instance, a detergent-solubilized membrane protein, photosynthetic reaction center (RC)
from Rhodobacter spaheroides, was functionalized with a biotinylated
lipid and immobilized on streptavidin beads to study the interactions by
RC to c-type cytochromes [350]. ILC has also been applied to study the
interactions of drugs with membranes and to screen for membrane-penetrable compounds [340–347]. As an example, liposomes immobilized
in capillary columns containing silica monoliths have been utilized to
separate acidic, basic, and neutral drugs [346]. Liposomes immobilized
on silica microspheres have been employed for the screening of bioactive compounds in some types of traditional Chinese medicine [340]. A
support containing N-hexadecyl iminodiacetic acid was used to adsorb
Cu2+ on liposomes for the purification of his-tagged proteins [351]. Lipid
metal ion interactions have also been studied using ILC [352, 353], as
has been demonstrated in the use of a zwitterionic lipid immobilized on
non-porous Stober silica particles to examine interactions of the lipid
with group I and II metal ions [352].
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Lipids can also be employed as biomimetic membranes in the form
of lipodiscs, nanodiscs, and lipid rafts [130, 321, 322, 351]. Lipodiscs
are made up of a circular planar bilayer that is usually stabilized by lipids modified with polyethylene glycol head groups; these lipodiscs can
then be covalently immobilized on diol silica [354]. The intra- and extracellular sides of the lipodiscs are exposed to the bulk solution; this
means that when the lipodiscs are functionalized with membrane proteins, the active site of the membrane protein will be exposed to the surrounding environment [354]. In one recent report the integral membrane protein human aquaporin-1 was immobilized on lipodiscs and
used in WAC for the fragment screening of integral membrane proteins
[354]. Nanodiscs are composed of self-assembled bilayers of phospholipids and a membrane scaffold protein (e.g., from human serum apolipoprotein A1) [130]. The nanodiscs have been immobilized on monoliths modified with streptavidin and by using a biotinylated membrane
scaffold protein (adenosine A2A receptor) for the detection of G-proteincoupled receptor-bound weak affinity fragments [130]. Lipid rafts consist of microdomains that are enriched in dynamic assemblies of sphingolipids or cholesterol, as have been used on silica for the screening of
anti-cancer agents in traditional Chinese medicine [324, 325].
4.1.9 Nucleic Acids

Another set of biological binding agents that have been used in affinity chromatography is nucleic acids [355–364]. For instance, DNA is
used as the affinity ligand in the method of DNA affinity chromatography to bind and isolate DNA-binding proteins [355–362]. Examples
of proteins that bind DNA and that have been purified or isolated by
this approach include helicases, restriction enzymes, polymerases, primases, topoisomerases, teleomerases, DNA repair proteins, histones,
and transcription factors [355–359, 363, 364]. The binding agent that
is used in this approach may be either a general preparation of fragmented nuclear DNA or a specific section of DNA. A general preparation would be used to separate DNA-binding proteins from sample
components that are not able to bind DNA [355]. A specific section of
DNA would be employed as the ligand in a situation where the goal is
to bind a target that has a specific interaction with the selected DNA
section or sequence [355, 364].
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Another group of ligands that are typically based on nucleic acids
are aptamers [365]. Aptamers are synthetic oligonucleotide sequences
(i.e., DNA and RNA) that are tailored to bind to specific target molecules [365–367]. These targets may include proteins, nucleotides, viruses, or small molecules. Aptamers are often generated through a selection process called the systematic evolution of ligands by exponential
enrichment (SELEX) [365–370]. SELEX is a technique that can be used to
screen for and amplify (e.g., the polymerase chain reaction) a specific oligonucleotide sequence that has a high affinity toward the desired target,
beginning with an initial large library of potential binding agents [365].
In affinity chromatography, an aptamer can serve as a stationary phase
by immobilizing this agent onto a column and using this to interact with
a particular target analyte [366, 370]. Target recognition with this type
of binding agent is based on the unique three-dimensional structure of
the aptamer, which can form pockets and interaction regions with relatively high affinities and good specificities [368, 369, 371]. These advantages, along with the ability to generate aptamers by synthetic means and
through combinatorial methods, have made this group of affinity ligands
attractive in recent studies as alternatives to antibodies [372–375].
Aptamers have been used as binding agents in columns to bind both
small and large targets [376–386]. Small molecules like mycotoxins and
aflatoxin have been purified and enriched by aptamer affinity chromatography [379, 381–383, 386]. Columns containing aptamers have also
been used to isolate recombinant proteins and therapeutic monoclonal
antibodies [377, 379, 384]. Monolith columns containing aptamers have
been described [376, 378, 383, 386], and aptamers have been combined
with multi-walled carbon nanotubes and gold nanoparticles for protein
purification [376, 380].
4.2 Non-Biological Agents as Affinity Ligands

A variety of non-biological binding agents are also often considered to
be stationary phases that fall within the field of affinity chromatography
(see Table 3). Examples of these binding agents are boronates, dye-ligands, immobilized metal ion chelates, and molecularly imprinted polymers [1, 3]. This section will examine the basis behind the use of each
of these binding agents as affinity ligands and recent developments that
have occurred with these stationary phases.
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Table 3 Types of Non-Biological Binding Agents Used in Affinity Chromatography
Type of Binding
Agent

Targets

Boronates

cis-Diol containing compounds:
glycoproteins, nucleosides,
catecholamines
		
Dye-ligands

Various enzymes and proteins
purification of enzymes and
		
Metal-ion
Various biological agents that
chelates
bind to specific metal ions
		
		
		
Molecularly
imprinted
polymers

Targets that are complementary
to the binding pockets formed
within the imprinted polymer

Examples of Applications
Boronate affinity chromatography;
boronic acid-lectin affinity
chromatography; biospecific
adsorption

Dye-ligand affinity chromatography; 		
proteins

Immobilized metal-ion affinity
chromatography; purification
of his-tagged proteins;
enrichment and extraction
of phosphopeptides
Solid-phase extraction;
chiral separations

4.2.1 Boronates and Related Mixed Ligands
Boronates have emerged as a useful and reliable set of affinity ligands for
the selective recognition, separation, and enrichment of glycoproteins,
nucleosides, catecholamines, and other cis-diol-containing compounds
[387–390]. Targets that contain cis-diol groups are often important in
fields such as glycomics, cancer-cell targeting, and disease diagnostics
[391–398]. The principle of boronate affinity chromatography (BAC) is
based on the covalent formation of a cyclic ester when boronic acid or
one of its derivatives reacts with a cis-diol-containing molecule. This reaction usually takes place when the pH of the reaction environment is
greater or equal to the pKa of the boronate that is used as the binding
agent. This cyclic ester dissociates when the pH of the environment is
below the pKa of the binding agent, which allows for elution and release
of the captured target [387–390].
Some common boronates that are used as ligands in BAC are 3-aminophenylboronic acid and 4-vinylphenylboronic acid, which have pKa
values of 8.8 and 8.2, respectively [389, 390]. However, the use of these
boronate ligands is hampered in terms of the weak binding properties
they have at the typically more neutral pH of biological samples [389,
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390, 399–402]. This has given rise to the synthesis and use of new boronates with lower pKa values, such as Wulff-type boronic acids, benzoboroxoles, phenylboronic acids with electron-withdrawing groups (e.g.,
sulfonyl, fluoro, or carbonyl groups) on the phenyl ring, and heterocyclic
boronic acids [90, 390, 403–417]. These boronic acid ligands have been
shown to have enhanced binding at neutral or acidic pH values compared
with conventional boronates, leading to improved binding strength and
extraction efficiency [390, 403, 418–420].
Boronate ligands and BAC have been used in many recent applications
[402]. Examples are the use of boronates and BAC for the enrichment, selective separation, and analysis of nucleosides, flavones, glycoproteins,
glycopeptides, carbohydrates, and other cis-diol-containing compounds.
These applications have been carried out with such matrices as urine, serum, and other biological samples that could be processed under acidic or
neutral pH conditions [402, 404–407, 410, 415–418, 421–431].
Mixed affinity ligands based on boronates plus other binding agents
have also been used for the separation of biomolecules in affinity chromatography. One example is the combination of a boronic acid and lectin
to give a method known as boronic acid-lectin affinity chromatography,
which is also referred to as BLAC or BAD-lectin affinity chromatography [432–435]. This combination overcomes the difficulty of using boronic acids to differentiate different glycoforms, as can be achieved by
adding a lectin to the same stationary phase [432, 435]. Although the
number of lectins that have been used in this approach is still limited,
these binding agents have been used with boronates to purify, with high
specificity, some classes of glycans with cis-diol groups [435, 436]. The
stationary phase in this method is often prepared by mixing a support
that contains an immobilized lectin with another support that contains
a boronate [433, 435]. BLAC is usually used for comparative glycosylation profiling. For example, a BLAC column was used to isolate and enrich N-linked glycans labeled with 8-aminopyrene-1,3,6-trisulfonic acid
(APTS) from prostate cancer patients [433] and N-linked glycopeptides
from HeLa cells [435].
4.2.2 Dye-Ligands

A dye-ligand is another type of synthetic binding agent that has been
used in affinity chromatography [365, 437, 438]. This combination is
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sometimes called dye-ligand affinity chromatography, which is a type
of biomimetic affinity chromatography [365]. A common example of a
dye-ligand is Cibacron Blue 3GA. Other examples are Procion Red HE3B and Procion Yellow H-A [365, 437]. Dye-ligands typically consist of
two parts: a portion that binds to the given target and a reactive group
for covalent attachment of the dye to a support [365, 437, 438].
The earliest application of a dye-ligand for affinity chromatography
was the use of Blue Dextran for enzyme purification [439]. Dye-ligands
are now commonly used in columns for protein and enzyme purification
due to the ability of such ligands to interaction with a variety of proteins
and the ability to modify the structure of the dye-ligand to alter its specificity [437, 438, 440, 441]. The modification of a dye-ligand and the design of derivatives for a given target can be aided by using computational
chemistry [440]. Recent reported applications of dye-ligands as binding
agents in affinity chromatography have involved the use of these agents
for the purification of fucosidan, lactoferrin, and lactoperoxidase from
food by-products and biological matrices [442–445].
4.2.3 Immobilized Metal-Ion Chelates

Metal ions held in the form of immobilized chelates are another type of
non-biological binding agent that has been employed in affinity chromatography [3, 446]. This method is known as IMAC [3, 446]. IMAC is
based on the interaction between chelated metal ions and residues on
some amino acids (e.g., cysteine, histidine, and tryptophan) that can act
as electron donors [446–448]. In IMAC, a chelating agent is immobilized
onto a material such as silica, cellulose, agarose, or a cryogel and used
to hold metal ions through coordination bonds [446–451].
Selection of the proper chelating ligand and metal ions can affect the
stability of this metal-chelating agent complex and the resulting retention
of targets that bind to this support. Iminodiacetic acid (IDA), nitrilotriacetic acid (NTA), carboxymethylated aspartic acid (CM-Asp), diethylene triamine pentaacetate (DTPA), and tris(carboxymethyl) ethylene-diamine
(TED) are some examples of chelating ligands that have been used in IMAC
[446–448, 450]. Metal ions like Ni2+, Cu2+, and Zn2+ are typically used to
bind targets that contain nitrogen, oxygen, or sulfur atoms that are accessible. On the other hand, metal ions such as Cu+, Ag+, Pd2+, Cd2+, and Hg2+
can be used to bind targets that contain sulfur [447, 449, 450, 452].
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IMAC has been employed in the selection of DNA aptamers and in protein purification for targets such as Fab fragments, monoclonal antibodies, and phosphopeptides [451, 453–465]. In proteomics, IMAC has taken
on an important role in the enrichment and extraction of phosphopeptides from samples [454–458]. Some recent platforms that have been reported include the use of IMAC with magnetic microspheres, O-carboxymethyl chitosan Schiff base complexes, and capillary-channeled polymer
fibers [458, 463–465]. Hybrid methods that combine IMAC and capillary electrophoresis (CE) or that use multi-dimensional IMAC to purify
analytes from a complex sample have also been described [459, 466].
4.2.4 Molecularly Imprinted Polymers

Molecular imprinting is an alternative strategy for preparing supports
and stationary phases for affinity chromatography [467–469]. This technique makes use of a support that has binding pockets prepared within
it for binding recognition with the desired target [469]. A support that
is prepared in this way is often known as a MIP [467]. A MIP is often
made by either a covalent or non-covalent technique. In the non-covalent imprinting approach, the target analyte or template is mixed with
a functional monomer and cross-linking agent. After this mixture is allowed to polymerize, the template or target is washed away, leaving behind binding pockets that have the correct shape and arrangement of
functional units to bind to the desired target [467–469]. In covalent imprinting, the target molecule is covalently coupled to a functional monomer that is combined with the rest of the polymerization mixture. After
polymerization, the target is cleaved away by a chemical means, leaving
behind a cavity that can bind the target molecule [467, 469, 470]. Ionic
imprinting can also be utilized, in which metal ions act to enhance binding by the target analyte and functional monomer in an aqueous solution [467, 469, 470].
Molecular imprinting has been used in many reports to make supports for chiral separations; however, it has also been widely used in
solid-phase extraction and some chromatographic techniques [467–
479]. For example, a MIP support has been used for solid-phase extraction and coupled with ligand exchange chromatography to screen
for chiral drugs in urine [475]. MIPs have also been employed in many
studies for the binding and isolation of low-mass targets and have
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been developed for use with larger molecules like proteins in applications such as diagnostics, drug delivery, environmental analysis, and
proteomics [467–482].
5 Applications of Affinity Chromatography
The applications of affinity chromatography have grown over the course
of the last decade [3]. These applications have included the utilization
of this method for the isolation of various chemicals and biochemicals,
as well as the use of affinity chromatography for sample pretreatment
or analysis [1–8]. There has also been continued work in using affinity-based separations as tools to study biochemical interactions [1, 3].
As shown in Figure 3, fields in which one or more of these formats
have been employed include biochemistry and biochemical research,
molecular biology, biotechnology, microbiology, cell biology, immunology, analytical chemistry, pharmacology or pharmaceutical sciences, and
biophysics [1–8]. Other areas of chemistry and related fields in which
affinity chromatography has been used are clinical chemistry, environmental chemistry, and food science [1, 3]. This section will examine the
recent developments that have taken place in applications of affinity
chromatography and the use of this method in these various areas.
5.1 Preparative Applications

One of the most popular uses of this technique has continued to be in
the purification of biological ligands. A variety of binding agents can be
used for this purpose. Examples are immunoglobulin-binding proteins,
antibodies, and antigens, as discussed earlier in Section 4.1 [221–229].
5.1.1 Enzyme and Protein Purification

The separation and purification of enzymes have long been an important
application of affinity chromatography [3, 438, 439]. Examples based
on triazine dyes as affinity ligands are the use of Cibacron Blue F3GA to
isolate microbial cellulase from rumen liquor [483], microbial xylanase
from rumen liquor [484], and proteases from pancreatic and stomach
extracts of fish by-products [485]. Hemicyanine dye has been used in a
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Figure 3 Common applications of affinity chromatography. This figure is based on a
search of the literature that was made with SciFinder in January 2019 for papers (total of 46,335 obtained) in the indicated areas and that were linked to the term “affinity
chromatography.” The figure is reproduced from Ref. [3] with permission from Elsevier.

similar manner to isolate peroxidase from a chewing stick [486], and
aminosquarylium cyanine dye has been employed for the purification
of lysozyme, α-chymotrypsin, and trypsin [487]. Azo dyes such as Reactive Orange 4 were utilized for the purification of malate dehydrogenase from a yeast cell homogenate [42].
IMAC can also be employed for the separation of enzymes. This
method is based on the interactions between a metal ion conjugate
such as Cu2+- or Zn2+-IDA that is placed onto a chromatographic support
and used to bind to histidine or cysteine residues [488–490]. In recent
work, a support containing Cu2+ complexed with IDA was employed for
the isolation of metalloprotease from a marine bacterium and for the
isolation of his-tagged chitinase [488, 489]. In a similar manner, Zn2+IDA has been utilized in an affinity method for the capture of camel
liver catalase [490].
Coenzymes and enzyme inhibitors are additional affinity ligands
that have been utilized for the purification of enzymes [25, 181, 491–
494]. 4-Aminobenzohydrazide and its derivatives have been used as enzyme inhibitors for the purification of plant peroxidase enzymes from
red cabbage and radishes [492, 493]. In addition, the enzyme inhibitor
β-lactosylamidine has been utilized for the purification of a cellulolytic
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β-glucosidase mixture of endo-acting endo-β-(1→4)-glucanase I and exoacting cellobiohydrolase I from Hypocrea jecorina [491]. Sulfanilamide
has been recently used as an inhibitor-based binding agent for lactoperoxidase in milk [181]. Riboflavin, a coenzyme which is flavin adenine dinucleotide (FAD)-dependent, was immobilized on Sepharose beads and
used to isolate cholesterol oxidase, a FAD-dependent enzyme expressed
in E. coli [494].
Affinity chromatography is also an important tool for the purification of other types of biomolecules [1, 2, 4–8]. This includes the utilization of affinity chromatography for the small- and large-scale purification of native proteins and recombinant proteins. Dye-ligand affinity
chromatography and related methods are often used for this purpose
[1, 2, 4–8, 365, 438, 440, 495, 496]. Smaller-scale applications of affinity methods for purification include the use of IMAC and Ni2+ chelate columns for the isolation of his-tagged proteins and the capture of antibodies or specific antigens by immunoaffinity columns [207, 208, 210,
220, 446, 448, 497, 498].
5.1.2 Purification of Viral Particles, Cells, and Related Targets

Affinity ligands attached to polysaccharide supports such as agarose or
cellulose have been employed for the purification of viral particles and
related agents [320]. Heparin is one ligand that has been covalently immobilized on agarose beads for the purification of whole viruses and
virus-like particles [320–322]. Con A and camelid antibody fragments
have both been used as binding agents for the purification of recombinant virus vectors in gene and cellular therapy [499, 500]. Affinity chromatography utilizing Cellufine sulfate as a binding agent has been used
for the isolation of Japanese encephalitis virus derived from Vero cells,
as well as for purification of the whole virus produced in Vero cell cultures for the development of a yellow fever vaccine [501–505].
The interactions between metal ion chelates and amino acid residues
in IMAC have been used in several reports for applications related to viruses and viral proteins. This approach has been employed for the purification of his-tagged nucleocapsid and matrix proteins of the Nipah
virus [506, 507]. This method has also been used to isolate his-tagged
recombinant viral vectors that are related to gene therapy [508] and the
virus responsible for foot-and-mouth disease virus for use in vaccine
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formulation [509]. IMAC has further been used to purify the hepatitis B
viral protein HBcAg from E. coli cell lysates [510, 511]. Cu2+-based IMAC
has been employed for the inactivation of viruses during the manufacturing process of plasma coagulation factors such as plasma-derived coagulation factor VIII and coagulation factor IX (Replenine-VF) [512, 513].
Antibody-binding proteins and antibodies attached to agarose-based
supports have been both used to examine viral clearance [320, 514–
517]. For example, native protein A [516] and alkali-stabilized recombinant protein A [515] have been employed for clearance studies involving
endogenous retroviral particles that are present in antibody feedstock.
Monoclonal antibodies to recombinant coagulation factor VIII have been
used for the purification of antihemophilic factor VIII compounds [513,
518–520]. The latter approach has also been used in a mixed-mode
resin to extract and purify a recombinant factor VIII with a truncated
B-domain [521].
Cell affinity chromatography is a recent form of bioaffinity chromatography that has been used to isolate and separate certain cells with
high purity [22, 522, 523]. Cell separations in this technique are carried
out based on the interaction between binding agents such as lectins or
monoclonal antibodies with cell surface markers such as glycoproteins
and receptors [522–524]. Some supports that have been used in cell affinity chromatography are magnetite and several forms of monoliths
[524– 527]. The separations of cell subsets with a high purity and on a
small scale have been accomplished by combining a microfluidic device
with the use of aptamers as binding agents [528–532]. Cell affinity chromatography has also been recently employed for counting cancer cells
in samples, examining microbial interactions with specific glycans, and
following the viral infection of cells [525, 530–533].
5.2 Analytical Applications

Many of the same binding agents described earlier have made affinity
chromatography a useful tool in analytical applications employed for
sample pretreatment and preparation [3, 11, 219, 534–536]. Most of
these applications employ the on/off elution mode of affinity chromatography, as shown earlier in Figure 1, due to the relative simplicity
and speed of this approach [3, 5, 219]. However, isocratic elution is also
used when the interactions involved have weak or moderate binding
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strengths, as occurs in WAC. This second situation is commonly used in
the use of affinity chromatography in chiral separations, as discussed
in the next section.
One way in which affinity chromatography is often used for chemical
analysis is as a tool for sample pretreatment [1, 3, 219, 534–536]. For example, MIPs have been employed in solid-phase extraction as a means of
sample preparation for the analysis of various target compounds [211,
473, 475]. Columns and supports that contain antibodies have been used
in many reports for the immunoextraction of a specific target from a mixture prior to the use of a second analytical method such as HPLC, gas
chromatography (GC), mass spectrometry, or capillary electrophoresis
(CE) [208, 210, 219]. These techniques, which are a type of IAC, have
been used for examining targets in a variety of clinical, pharmaceutical,
and environmental samples [210, 219, 537]. A related application of affinity chromatography is immunodepletion, in which a set of specific
agents are removed from a sample prior to the analysis of other sample
components [46]. Immunodepletion has been used in recent studies as
a means for removing proteins that occur at a high abundance prior to
analysis of lower abundance proteins [46, 537–539].
It is also possible to use affinity chromatography to directly measure
a particular target in a sample [3, 219]. This is often done by using affinity chromatography as part of HPLC systems, and often in the form of
HPAC. Binding agents that have been used for this purpose are antibodies/antigens, immunoglobulin-binding proteins (e.g., protein A or protein G), immobilized metal ion chelates (i.e., IMAC), boronates, and lectins [534–536]. Direct detection of the captured and eluted target can be
carried out in these methods if this target is present at a sufficient concentration to allow it to be monitored by its absorbance or fluorescence,
by using mass spectrometry, or by employing a post-column reactor for
detection [208, 219]. Affinity columns have further been employed in
multi-dimensional methods by combining them with reversed-phase
liquid chromatography, CE, or GC [219].
Targets that are present at low concentrations can be detected by
using affinity chromatography with indirect detection. This strategy is
often employed when affinity columns are used with antibodies or related binding agents to create a chromatographic immunoassay [208,
210, 219]. For example, a target analyte may be required to compete
with a labeled analog for binding sites on an immunoaffinity column
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that contains a limited amount of immobilized antibodies for the target
and analog. This creates a situation in which the amount of labeled analog that is captured will be affected by the amount of target that was
present in the sample, thus providing a means for indirectly determining the sample concentration for the target [208, 210, 219]. Many formats have been described for chromatographic immunoassays. These
formats include traditional competitive-based methods, as well as displacement assays, sandwich assays, and one-site immunometric assays
[210, 217, 219, 540–544].
5.3 Chiral Separations

Chiral separations are another important application of affinity chromatography [3, 11, 220, 280–284]. Polysaccharides such as amylose and
cellulose have been used as CSPs to carry out enantioseparation of various chiral drugs and solutes [3, 112, 280, 282, 283, 285, 286]. Examples
that have used amylose-based CSPs have included the chiral separation
of chemopreventive chiral isothiocyanates, pesticides, β-amino acid derivatives, lysine derivatives, coumarin derivatives, butyrolactones, and
fungicides [545–551]. Other applications have included sulfoxide-containing drugs, antihistamines, simendan, piperine-2,6-diones, local anesthetics, calcium channel blockers, clausenamidone/neuclausenamidone,
anticholinergic drugs, and various profens [547, 552–558]. Additional
examples have used cellulose-based CSPs in HPLC for the separation
of sulfoxides, alkaloid analogs, β-blockers, local anesthetics, β-amino
acid derivatives, anti-fungal drugs, and psychoactive drugs [548, 555,
559–564].
Various chitin and chitosan derivatives have been used as CSPs [281,
282, 288– 295]. These stationary phases have been used for the chiral
recognition of solutes such as benzoin, triazole fungicides, Troger’s base,
and methylphenyl sulfoxide [288, 289, 291–294]. This class of CSPs has
further been employed in enantioselective separations of voriconazole,
glutethimide, citalopram hydrobromide, 1-phenyl ethane- 1,2-diol, and
flavanone [288, 289, 291–293].
As discussed in Section 4.1.7, derivatives of β-cyclodextrin have often
been exploited in affinity chromatography and HPLC systems to carry out
chiral separations [11, 112, 282, 283, 296, 297]. Cationic β-cyclodextrin
CSPs prepared by click chemistry have recently gained popularity for the
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chiral selection of analytes such as β-blockers, racemic β-nitro ethanol
derivatives, profens, amino acid derivatives, flavonoids, aromatic alcohols, acidic drugs, benzene homologues, and isoxazolines [298–302]. A
hybrid support prepared by coupling β-cyclodextrin with piperidine,
L-proline, and an ionic liquid with 3,5-diamino-1,2,4-triazole has been
used to separate pyrrolidine and several chiral drugs [304]. Another hybrid support made by hybridizing β-cyclodextrin with ethane, triazinyl,
and 3,5-dimethyl phenyl functional groups has been applied for enantioselective separation of anilines, phenols, aromatic hydrocarbons, phenols, and acidic compounds [305].
Several variations on cyclodextrin-based CSPs and related stationary phases have been described in recent reports. β-Cyclodextrin immobilized on monolithic supports has been employed for separation of β-blockers, α-blockers, anti-fungal drugs, catecholamine,
sedative hypnotics, anti-arrhythmic drugs, and antihistamines [303].
β-Cyclodextrin CSPs prepared by light assistance have been utilized for
separating promethazine, benzoin, and chlortrimeton [306]. Bridged bis
(β-cyclodextrin)-based CSPs have been used for the separation of chiral
drugs, pesticides, and triazole fungicides [307, 308]. A mixed-mode stationary phase based on β-cyclodextrin has been utilized for the enantioseparation of warfarin, styrene oxide, and 1-phenyl-1-propanol using reversed-phase elution conditions, while profens such as ibuprofen
and ketoprofen were separated by this material and employing a polar
organic elution mode [309]. Aromatic derivatives of the macrocyclic oligosaccharide cyclofructan have been utilized for the chiral recognition
of analytes such as warfarin, furoin, Troger’s base, 2-napthol atropisomers, and novel spirobassinin analogs [315–318]. A cyclofructan 6 CSP
prepared by click chemistry has been employed for the chiral selection
of amine and alcohol derivatives [319].
Proteins such as serum proteins and enzymes have also been employed as CSPs [3, 11, 112, 283]. Serum proteins such as HSA [68, 565,
566] and AGP [567–570] have been immobilized on silica particles or
monoliths to study the interactions of these proteins with chiral solutes.
For instance, AGP from chicken egg white was covalently immobilized
on aminopropyl silica for the chiral recognition of benzoin, ibuprofen,
chlorpheniramine, propranolol, and oxprenolol [570]. An affinity support that contained HSA covalently immobilized to silica and modified
with the cross-linking agent bis-maleimidohexane was prepared and
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examined for its chiral selection of drugs such as warfarin, verapamil,
and carbamazepine [566]. A related serum protein, BSA, has been used
as in a mixed-binary CSP that was prepared by grafting BSA and the antibiotic eremomycin for chiral separation of various profens [571].
The ability of enzymes such as penicillin G acylase, glucoamylase, and
cellulase to act as CSPs was discussed in Section 4.1.4 [243–247]. Recently, lysozyme was covalently immobilized to mesoporous polyimide
achiral covalent organic frameworks for the chiral separation of various
amino acids and drugs, such as threonine, leucine, tryptophan, ofloxacin, metoprolol, and chlorpheniramine [572]. Pepsin has been covalently
immobilized within silica monoliths and used to carry out a chiral separation for the analgesic nefopam [573].
As mentioned in Section 4.2.4, MIPs are another type of material that
have frequently been explored for use as CSPs [283, 574]. Various polymerization techniques have been applied for the preparation of MIPbased CSPs. Examples of these techniques are imprinting in preformed
beads, precipitation polymerization, suspension polymerization, multistep swelling and polymerization, and surface imprinting [575–582].
Supports with which MIPs have been combined for chiral separations
include organic polymer-based particles, monoliths, membranes, and
alignate monospheres [583–590]. For example, a MIP-based CSP using
monodisperse hybrid silica microspheres was prepared with l-phenylamine as the template, methacrylic acid and acryloyl-β-cyclodextrin as
the functional monomers, and ethylene glycol dimethacrylate as the
cross-linker; this support was then used to separate a racemic mixture
of phenylalanine [583]. Another MIP based on a monolithic column and
using 4-vinylpyridine as the functional monomer, ketoprofen as the template, and ethylene glycol dimethacrylate as the cross-linking agent, was
used for the chiral separation of ketoprofen [587].
5.4 Biointeraction Studies

Affinity chromatography can also be employed as a tool for biophysical
applications such as studies of solute–ligand interactions. In this technique, useful information on equilibrium and rate constants, and the
number and types of affinity sites, can be obtained [11, 13, 14, 16]. Advantages of using this approach in such a way, especially when carried
out on an HPLC system, are the speed, precision, and ease of automation
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that can be obtained [14]. Methods that have been used for this purpose,
as discussed in this section, are zonal elution, frontal analysis, and various techniques for kinetic studies [13, 14, 16].
5.4.1 Zonal Elution Methods

Zonal elution is an approach that has frequently been used in affinity
chromatography to characterize the strength of solute–ligand interactions [3, 11, 46]. In this approach, a small volume of an analyte or probe
compound is introduced into an affinity column that contains an immobilized ligand [11, 46]. The mobile phase used for the elution of the analyte or probe often contains a possible competing agent that is present at
a known concentration; the pH, ionic strength, polarity, or temperature
of the mobile phase may also be altered, as desired [11, 46, 591, 592].
Based on the retention time that is observed for the injected compound
and the void volume of the column, the binding strength and type of interactions that are present on the affinity ligand for the injected analyte/probe and competing agent can be determined [3, 11, 46, 591, 592].
Besides being used to examine interactions of solutes with native
serum proteins, zonal elution has been utilized in recent reports to
study the interactions of drugs with modified forms of proteins such as
HSA and AGP [13, 162, 163, 592–597]. Zonal elution has also been employed with affinity columns for characterizing the interactions of Con
A and AAL with AGP [48], the binding of protein G with rabbit IgG [137],
and the binding of drugs such as acetaminophen and ketoprofen with
β-cyclodextrin [310–313]. This method has also been used to investigate the interactions of drugs or bioactive compounds with epidermal
growth factor receptor, β2-adrenoceptor, and α1A-adrenoceptor in cell
membrane chromatography [138, 598–601].
Various types of information that can be obtained from zonal elution
experiments [11, 46, 591, 592]. This information can include the equilibrium constant(s) for an interaction, the location of a given binding
site (i.e., through the use of site-selective probes), and the type of competition that is occurring between a given set of solutes for the binding agent. The effect of pH, solvent composition, and temperature on
the binding strength and type of interaction that is present can also
be examined by this approach [11, 46, 591, 592]. For example, zonal
elution has been employed with affinity microcolumns to study the
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effects of glycation on interactions of the sulfonylurea drug tolazamide with HSA [134]. In another study, a zonal elution format was
used with an anti-AGP column and adsorbed samples of AGP to look at
the changes in binding by various drugs with purified or normal AGP
and AGP from patients with lupus [593]. Zonal elution was also used
in a recent report to examine the competition between folic acid and
5-aminosalicylate for HSA [602].
5.4.2 Frontal Analysis Methods

Frontal analysis is another affinity chromatography technique that is
employed to study solute–ligand interactions [3, 11, 46, 260, 592]. The
most common way of carrying out frontal analysis is by using a series
of analyte solutions that are applied separately to a column, and with a
washing step being used after each solution [3, 11, 46, 592]. In this format, the column is first equilibrated with the application buffer, with a
known concentration of the target then being passed through the affinity column until a breakthrough curve is formed. The retained target is
next washed from the column and this process is repeated using another application of the target at the same or different concentration
[3, 11, 46, 592]. If relatively fast association and dissociation are occurring between the target and affinity ligand during the timescale of this
experiment, the central position of the breakthrough curves can be related to the corresponding concentrations of the applied target to produce a binding isotherm. This isotherm is then fitted to one or more
binding models to obtain the equilibrium constants and moles of binding sites that the immobilized binding agent and column have for the
target [3, 11, 46, 592].
A relatively wide range of targets and binding agents has been examined in recent reports by affinity chromatography and the traditional
form of frontal analysis [603–624]. Many of these studies have involved
the analysis of binding by drugs or solutes with serum proteins such as
HSA and AGP [3, 15, 162, 163, 592, 593, 596, 602, 603]. This approach
has been used for studying the interactions of drugs with membrane protein and nuclear receptors, including voltage-dependent anion channel 1,
G-protein-coupled receptors such as GPR17, nicotinic acetylcholine receptors, P-glycoproteins, β2-adrenergic receptors, dopamine receptors,
and angiotensin-converting enzyme 2 receptors [330–332, 334–336,
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604–610]. Antibody–antigen binding [616, 617] and fucose-specific lectin-fucosylated glycan interactions [618] have been examined by frontal
analysis using affinity columns. Additional systems that have been characterized by affinity chromatography and frontal analysis span from the
binding of boronates with cis-diol compounds [611, 612] to the binding
of thrombin with phenolic acids [613] and the interactions of β2-agonists
with MIPs [614]. Frontal analysis has also been used to determine the
complexation stability constant and total moles of binding sites for Cu2+
ions with regards to l-glutamic acid [615].
Another format that has been explored for frontal analysis is the
stepwise application of target solutions to an affinity column [260,
619–621]. In this technique, the column is again first equilibrated with
the application buffer with no target present. This is followed by the
continuous application of the target in solutions going from a low to
high concentration, producing a continuous breakthrough curve where
a plateau is reached for each concentration and step in this process
[260, 619–621]. Because this process is continuous and does not require washing steps in between the applied solutions of the target,
it can require less of the target than traditional frontal analysis. This
last feature has made this method attractive for use in cell membrane
chromatography [619, 620]. For example, stepwise frontal analysis has
been employed to obtain a dissociation equilibrium constant for the
interaction of α1A adrenergic receptor with natural products and drugs
such as dehydroevodiamine, tamsulosin, silodosin, oxymetazoline, and
schizandrin A [601, 619, 620].
Frontal affinity chromatography coupled to mass spectrometry (FACMS) has become an important tool for the high throughput screening of
drug candidates against immobilized membrane receptor protein targets [331, 607, 622–624]. In this technique, the breakthrough curve for
an applied target is followed by MS as the target interacts with an immobilized binding agent [331, 607, 622–624]. There are two modes in
which FAC-MS may be employed: the indicator mode and Q1 scan mode
[331, 607, 622–624]. The indicator mode is based on how the presence
of a competitor in the mobile phase causes a shift in the binding of an
applied target with the immobilized binding agent [607]. For instance,
FAC-MS has been used with adsorption energy distribution calculations
to study the adsorption of salbutamol on β2-adrenogenric receptor that
was immobilized on polystyrene amino microspheres [607]. The shift
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seen in this breakthrough curve for salbutamol was then examined in
the presence of mobile phases that contained competing agents such as
paeoniflorin, liquiritin, and a mixture of six compounds to see if FAC-MS
could be employed for screening of site-specific bioactive chemicals in a
complex matrix [607]. The second mode in which FAC-MS can be used
is the Q1 mode. In this mode, multiple targets are screened simultaneously against a given binding agent and are ranked based on their affinity for this binding agent when it is used as a stationary phase [331,
624]. This mode has been employed for the screening of ligands against
human estrogen receptor β and a G-protein coupled receptor [331, 624].
5.4.3 Methods for Kinetic Studies

Affinity chromatography has been used to study the kinetics of various
solute–ligand interactions [16, 625–627]. The most common format for
this work is to examine the retention or peak shape that is obtained for
a target that is applied or injected onto an affinity column that contains
an immobilized form of the desired binding agent [16, 625–627]. Examples of techniques for kinetic studies that make use of this general format include those that use band-broadening measurements (e.g., the
plate height and peak profiling methods) [202, 310, 311, 313, 628–632],
peak decay analysis [137, 633–635], the split-peak effect [636–638], and
peak fitting [598, 632, 639–641].
The plate height method and related technique of peak profiling for
kinetic analysis both make use of band-broadening measurements [202,
310, 311, 313, 628–632]. These methods are based on the application of
a small volume of a target under linear elution conditions onto an affinity column and control column at one or several flow rates; the degree
of band-broadening is then compared on these two types of columns to
obtain the contribution due to stationary phase mass transfer. This value,
in turn, can be used with the known flow rate and measured retention
factor for the target on the affinity column to determine the dissociation rate constant for this interaction process [628, 629]. Peak profiling
has been utilized to examine the interactions of various drugs with the
serum proteins AGP and HSA [262, 630, 631] and with β-cyclodextrin
[310, 311, 313]. This method has further been used to examine the interactions of membrane receptors with drugs and bioactive compounds
[242, 632].
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Peak decay is another method that can be employed for kinetic analysis in affinity chromatography [137, 633–635, 641]. This method involves the application of a target solute onto both an affinity column and
control column in the presence of high flow rates and/or mobile phase
conditions that prevent rebinding of the target as it is dissociated for an
immobilized binding agent. This method can be performed in both competitive and non-competitive formats, depending on whether a competing agent is added to the mobile phase to promote target release and to
avoid rebinding to the affinity column [137, 633–635, 641]. Peak decay
has been employed with affinity chromatography for the analysis of various systems. Examples include studies of drug dissociation from serum
proteins such as HSA and AGP [633–635], work examining antibody–antigen interactions [137], and studies of the interactions of β2-adrenergic
receptor with a number of drugs [641].
Another kinetic technique that employs an immobilized binding
agent is the split-peak method. The split-peak method makes use of
conditions in which a target binds irreversibly to the affinity ligand but,
due to the short time allowed for this binding, a small fraction of the
target also passes through the column as a non-retained peak [636–
638]. The relative amount of target that is in the free vs. retained fractions at various flow rates can be used to obtain information on the
association rate constant for the target with the immobilized binding
agent or on the rate of stagnant mobile phase mass transfer in the column [633–635, 641]. This technique has been used to study antibody–
antigen interactions and the binding of protein A and protein G with
immunoglobulins [636–638].
The peak fitting method is performed by injecting various concentrations of a target onto an affinity column and looking at the retention and
shape of the resulting peak as the sample concentration is varied [598,
632, 639–641]. By fitting these peaks to various models, it is possible
to obtain the rate constants for interactions by the target with the affinity ligands. Peak fitting has been used in both zonal elution and frontal
analysis formats for studying the interactions of drugs with immobilized
receptors such as β2-adrenergic receptor and nicotinic acetylcholine
receptor [598, 632, 639–642].
An alternative format for kinetic studies is to apply a small target in
the presence of a soluble binding agent onto an affinity column which
contains an immobilized binding agent for the target. This immobilized
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binding agent may be the same as the soluble binding agent or a different ligand, and acts as a secondary probe to extract the unbound fraction of the solute from the sample [16, 139–142, 625–627, 643]. This
technique is known as ultrafast affinity extraction. This method makes
use of a short time for extraction of the target by employing mediumto-high flow rates and small affinity columns. This approach has been
used to provide information on both the thermodynamics and kinetics
of the interactions between a number of drugs or hormones and serum
transport proteins such as HSA, AGP, and sex hormone-binding globulin
[139–142, 643]. Both single-column systems and two-column systems
have recently been described for ultrafast affinity extraction, with the
single-column system being used for kinetic studies [139–141].
6 Conclusions
Affinity chromatography and related techniques based on supramolecular interactions have continued to expand and be adapted as tools for
achieving selective separations and in examining the components of
complex samples. A few examples that were discussed in this review
included improvements in natural, inorganic, and synthetic supports for
affinity chromatography; the use of magnetic particles, smart materials,
and nanomaterials as new supports for affinity methods; and the continued development of support formats based on capillaries, packed beds,
monoliths, and microscale separations. In addition, advances and new
approaches have appeared in the development of new synthetic methods and tools, for covalent immobilization, biospecific adsorption, and
non-covalent immobilization in affinity chromatography.
The variety of biological and non-biological binding agents that may
be employed as stationary phases in affinity separations has also shown
continued growth and development. Biological agents that are now often
employed in affinity separations range from enzymes, antibodies, immunoglobulin-binding proteins, serum proteins, and lectins to biotin combined with avidin or streptavidin, carbohydrates, lipids, and nucleic acidbased ligands, including aptamers. Advances and ongoing work have
appeared as well in the use of non-biological ligands, such as methods
that employ boronates, mixed ligands, dye-ligands, immobilized metal
ion chelates, or MIPs.
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These advances in the components of affinity chromatography have
been associated with improved or expanded capabilities that allow this
method to be used for a broad set of applications. Affinity chromatography has remained an important separation method for the purification of enzymes, native proteins, and recombinant proteins. However,
this method has also grown as an approach that can be used to purify
and characterize viral particles, cells, and related targets. Many analytical applications have continued to appear as well, such as the use
of affinity separations for sample pretreatment, the removal of specific
solutes from a sample (i.e., as part of immunoextraction or immunodepletion), and for the direct or indirect measurement of a particular target in a complex matrix (e.g., by means of chromatographic immunoassays). A related use of affinity chromatography for chemical purification
or analysis has been in the field of chiral separations. Finally, affinity-related separations have seen further advances in approaches by which
they can be used to study biological interactions by means such as zonal
elution, frontal analysis, or various formats that can be employed for kinetic studies. Overall, the variety of system components and formats that
may be used in affinity chromatography and related methods should
continue in the future to make these techniques popular and powerful
separation and analysis tools in fields such as analytical chemistry, biochemistry, clinical testing, environmental analysis, molecular biology,
and pharmaceutical science.
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